Causative relationship between diabetes mellitus and breast cancer in various regions of Saudi Arabia: An overview

Asian Pacific Journal of Cancer Prevention

Volumn 12, Issue 3, 2011, Pages 589-592

  Arif, Jamal M ^a   Al Saif, Ahmad M ^a   Al Karrawi, Mohammed A ^b   Al Sagair, Othman A ^a  

^a FREDERICK UNIVERSITY   (Cyprus)

^b Technical College of Food and the Environment   (Saudi Arabia)

Author keywords

Breast cancer; Diabetes mellitus; Obesity; Saudi Arabia

Indexed keywords

EID: 79958806523     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (37)

1. Abulkhair O (2009). Dietary fat, obesity, estrogen level and breast cancer risk in Saudi females: A case-control study. Cancer Res, 69 (24 Suppl), Abstract nr 6070.
2. Alimova IN, Liu B, Fan Z, et al (2009). Metformin inhibits breast cancer cell growth, colony formation and induces cell cycle arrest in vitro. Cell Cycle, 8, 909-15.
3. Al-Nozha MM, Al-Maatouq MA, Al-Mazrou YY, et al (2004). Diabetes mellitus in Saudi Arabia. Saudi Med J, 25,1603-10.
4. Al-Nozha MM, Al-Mazrou YY, Al-Maatouq MA, et al (2005). Obesity in Saudi Arabia. Saudi Med J, 26, 824-29.
5. Al-Nuaim AA, Bamgboye EA, Al-Rubeaan KA, Al-Mazrou Y (1997). Overweight and obesity in Saudi Arabian adult population, role of socio-demographic variables. J Community Hlth, 3, 211-23.
6. Al-Okail MS, Al-Daghri NM, Al-Attas OS, Hussain T (2009). Combined effects of obesity and type 2 diabetes contribute to increased breast cancer risk in premenopausal women. Cardiovascular Diabetology, 8, 33.
7. Al-Othaimeen AI, Al-Nozha M and Osman AK (2007). Obesity: an emerging problem in Saudi Arabia. Analysis of data from the National Nutrition Survey. East Mediterr Health J, 13, 441-48.
8. Al Sayed AD, Shoukri M, Al-Eid H, et al (2010). Breast cancer in the Kingdom of Saudi Arabia: A review of all female breast cancer cases from the Saudi Cancer Registry (SCR) from 1994-2004. J Clin Oncol, 28, (suppl; abstr e12042).
9. Bodmer M, Meier C, Krahenbuhl S, et al (2010). Long-term metformin use is associated with decreased risk of breast cancer. Diabetes Care, 33, 1304-8.
10. Cazzaniga M, Bonanni B, Guerrieri-Gonzaga A, Decensi A (2009). Is it time to test metformin in breast cancer clinical trials? Cancer Epidemiology, Biomarkers and Prevention, 18, 701-5.
11. Cleary MP, Grossmann ME (2009). Obesity and breast cancer: The estrogen connection. Endocrinology, 150, 2537-42.
12. Czajka-Oraniec I, Simpson ER (2010). Aromatase research and its clinical significance. Pol J Endocrinol, 61, 126-34.
13. Diabetes Atlas (2010). www.diabetesatlas.org
14. El-Hamzi MA, Warsy AS (1999). Obesity and overweight in Type II diabetes mellitus patients in Saudi Arabia. Saudi Medical J, 20,167-72.
15. El-Hamzi MA, Warsy AS (2000). Prevalence of overweight and obesity in diabetic and non-diabetic Saudis. East Mediterr Hlth J, 6, 276-82.
16. Fatani HH, Mira SA, El-Zubier AG (1987). Prevalence of diabetes mellitus in rural Saudi Arabia. Diabetes Care, 10, 180-3.
17. Flegal KM, Carroll MD, Kuczmarski RJ, Johnson CL (1998). Overweight and obesity in the United States: Prevalence and trends, 1960-1994. Int J Obes Relat Metab Disord, 22, 39-47.
18. Giovannucci E (2010). Diabetes and cancer: A consensus report. Diabetes Care, 33, 1674-85.
19. Goodwin PJ, Ennis M, Pritchard KI, et al (2002). Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study. J Clin Oncol, 20, 42-51.
20. Gonzalez-Angulo AM, Meric-Bernstam F (2010). Metformin: a therapeutic opportunity in breast cancer. Clin Cancer Res, 16, 1695-00.
21. Gunter MJ, Hoover DR, Yu H, et al (2009). Insulin, insulin-like growth factor-I, and risk of breast cancer in postmenopausal women. J Natl Cancer Inst, 101, 48-60.
22. Hamilton CJCM, Jaroudi KA, Sieck UV (1995). High prevalence of obesity in a Saudi infertility population. Annals Saudi Medicine, 15, 344-6.
23. International Diabetes Federation Report (2007). www.idf.org/annual-reports.
24. Jemal A, Siegel R, Ward E, et al (2010). Cancer Statistics 2009. CA Cancer J Clin, 59, 225-49.
25. Lorincz AM, Sukumar S (2006). Molecular links between obesity and breast cancer. Endocrine-Related Cancer, 13, 279 -92.
26. Michels KB, Solomon CG, Hu FB, et al (2003). Type 2 diabetes and subsequent incidence of breast cancer in the Nurses' Health Study. Diabetes Care, 26, 1752-8.
27. Mink PJ, Shahar E, Rosamond WD, et al (2002). Serum insulin and glucose levels and breast cancer incidence: the atherosclerosis risk in communities study. Am J Epidemiol, 156, 349-52.
28. Moschos SJ, Mantzoros CS (2002). The role of the IGF system in cancer: from basic to clinical studies and clinical applications. Oncology, 63, 317-32.
29. NCR Report (2003). Cancer Incidence Report, National Cancer Registry.
30. Osman AK, Al-Nozha MM (2000). Risk factors of coronary artery disease in different regions of Saudi Arabia. East Mediterr Hlth J, 6, 465-74.
31. Prentice AM and Jebb SA (1995). Obesity in Britain: Gluttony or sloth? BMJ, 311, 437-9.
32. Rice S, Pellatt L, Ramanathan K, et al (2009). Metformin inhibits Aromatase via an Extracellular Signal-Regulated Kinase-Mediated Pathway. Endocrinology, 150, 4794-01.
33. Sachdev D, Yee D (2001). The IGF system and breast cancer. Endocrine-Related Cancer, 8, 197-9.
34. Smith RA, Cokkinides V, Brooks D, et al (2010). Cancer screening in the United States, 2010: A review of current American Cancer Society guidelines and issues in cancer screening. CA Cancer J Clin, 60, 99-19.
35. Vigneri P, Frasca F, Sciacca L, et al (2009). Diabetes and cancer. Endocr Relat Cancer, 16, 1103-23.
36. Wild S, Roglic G, Green A, et al (2004). Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care, 27, 1047-53.
37. World Diabetes Foundation (2007). Obesity and Diabetes - Emerging Major Health Care Challenges in the Eastern Mediterranean Region. (http://www.worlddiabetesfoundation.org/media(4218,1033)/Pressrelease_Riyadh.pdf)